Literature DB >> 6123020

Evolution of infectious mononucleosis into Epstein-Barr virus carrying monoclonal malignant lymphoma.

W Abo, K Takada, M Kamada, M Imamura, T Motoya, M Iwanga, T Aya, S Yano, T Nakao, T Osato.   

Abstract

A monoclonal malignant lymphoma was diagnosed in a 30-month-old Japanese boy, who, since the age of 12 months, had had chronic, recurrent infectious mononucleosis manifested by repeated episodes of severe cough and high fever accompanied by marked lymphadenopathy and hepatosplenomegaly and high serum Epstein-Barr virus (EBV) antibody titres. The diagnosis of Burkitt's lymphoma was made when a cervical lymph-node biopsy specimen revealed massive proliferation of immature B-cells with starry-sky histiocytes. These lymph-node cells were characterised by a translocation between chromosomes 10 and 17. There were approximately 9 EBV genome-equivalents per cell. Most cells were positive for nuclear antigen (EBNA); early antigen (EA) and viral capsid antigen (VCA) were also detected. The presence of EBV was supported by finding that the cell-free lymph-node extract transformed cord-blood lymphocytes into EBNA-positive blast cells. The proportion of EA-positive and VCA-positive cells increased rapidly in culture for 24 h, then the positive cells degenerated rapidly and completely. The cells also contained numerous herpes-type virus particles. The child improved considerably with cytostatic treatment and has been in remission for 2 years.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123020     DOI: 10.1016/s0140-6736(82)92842-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  3 in total

1.  Immunological reason for chronic ill health after infectious mononucleosis.

Authors:  T J Hamblin; J Hussain; A N Akbar; Y C Tang; J L Smith; D B Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-09

Review 2.  Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.

Authors:  M A Epstein; A J Morgan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

3.  Lymphoproliferative disorders of the orbit: an immunological approach to diagnosis and pathogenesis.

Authors:  A Garner; A H Rahi; J E Wright
Journal:  Br J Ophthalmol       Date:  1983-09       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.